Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

41 results about "Potassium channel" patented technology

Potassium channels are the most widely distributed type of ion channel and are found in virtually all living organisms. They form potassium-selective pores that span cell membranes. Potassium channels are found in most cell types and control a wide variety of cell functions.

Bispecific Binding Molecule

A bispecific binding molecule having high selectivity for Kv1.3 but different affinity for integrin β7, a pharmaceutical composition thereof, and a use thereof. The bispecific binding molecule is formed by the fusion of a toxin polypeptide that binds to a Kv1.3-type potassium ion channel and heavy chain or light chain variable region CDRs of an antibody that specifically binds to integrin β7. The obtained bispecific binding molecule has higher selectivity for Kv1.3high β7high T cells (relative to Kv1.3low β7high T cells), and can greatly improve the therapeutic efficacy, while preventing possible adverse reactions caused by other cells that positively express integrin β7. The described difference in binding activity toward two targets enables the bispecific binding molecule to have a binding preference for the two targets, thereby having certain advantages in the design of antibody drugs.
Owner:YICHEN THERAPEUTICS LTD

Polysubstituted aryl derivative and preparation method therefor and use thereof

The present invention relates to a polysubstituted aryl derivative, a preparation method therefor, and the use of a pharmaceutical composition containing the derivative in medicine. Specifically, the present invention relates to a polysubstituted aryl derivative as shown in general formula (I), a preparation method therefor, a pharmaceutically acceptable salt thereof, and the use thereof as a therapeutic agent, in particular as a Kv1.3 potassium ion channel inhibitor, wherein the definition of each substituent in general formula (I) is the same as defined in the description.
Owner:ZHEJIANG HISUN PHARMA CO LTD +1

KCR1 mutant suitable for steady-state regulation and control of plant potassium ions and application of KCR1 mutant

ActiveCN120329403APlant peptidesFermentationBiotechnologyPotassium channel
The invention discloses a KCR1 mutant suitable for plant potassium ion steady state regulation and application thereof, and relates to the technical field of bioengineering, and the KCR1 mutant at least has T136A and G140A mutations on the basis of light-operated potassium ion channel protein KCR1. The invention also discloses a gene for coding the KCR1 mutant. The invention also discloses application of the KCR1 mutant or gene in plant culture, cultivation of new plant varieties or preparation of plant culture products. The KCR1 mutant disclosed by the invention has a blue-shift excitation spectrum compared with a wild type, can realize accurate regulation and control of plant potassium ion flow through illumination regulation and control, and has a relatively great application value in the aspects of light-controlled plant cultivation, plant potassium ion channel research and the like.
Owner:ZHENGZHOU UNIV

Potassium ion KV1.3 channel inhibitors

PCT designated stageWO2026003546A1Peptide/protein ingredientsUnknown materialsPotassium channelIonic Channels
The invention relates to potassium ion channel inhibitor compounds having improved affinity and selectivity for Kv1.3 ion channel, and enhanced stability. The inhibitor compounds comprise a polypeptide component which is a miniprotein. The invention also relates to therapeutic indications and diagnostic uses of the inhibitor compounds.
Owner:VRG MINIPROTEIN ZRT

Non-sterilization type mildew-proof antibacterial material capable of dynamically responding to thallus proliferation as well as preparation method and application of non-sterilization type mildew-proof antibacterial material

The invention discloses a non-sterilization type mildew-proof and antibacterial material capable of dynamically responding to thallus proliferation as well as a preparation method and application of the non-sterilization type mildew-proof and antibacterial material. The material comprises polyvinyl alcohol, carboxymethyl cellulose or a salt thereof and metal ions, and the polyvinyl alcohol, the carboxymethyl cellulose or the salt thereof are bridged through the metal ions; the metal ions comprise Li < + >. The material disclosed by the invention takes Na < + > released by thallus proliferation as a signal medium, releases Li < + > as required through a coordination-dissociation process, and further induces thallus cells to actively ingest Li < + > through metabolic deception of occupying a potassium ion channel by utilizing a hydration radius of Li < + > similar to K < + > according to the metabolic demand of sodium excretion and potassium ingestion in the thallus proliferation process; on one hand, bacterial cell replication lacks essential nutrient substance K < + >, and finally gradually declines; on the other hand, protein space conformation is changed and inactivated by capturing water molecules of intracellular protein, and the two aspects have a synergistic effect, so that the efficient mildew-proof and antibacterial effects of Li < + > at low concentration can be realized, and the effect is lasting.
Owner:DONGHUA UNIV

Butterfly-shaped potassium ion channel molecule with mechanical and pH dual regulation and control functions as well as preparation method and application of butterfly-shaped potassium ion channel molecule

The invention provides a mechanical and pH dual-regulated butterfly potassium ion channel molecule as well as a preparation method and application thereof, and belongs to the technical field of biomimetic materials. According to the butterfly-shaped potassium ion channel molecule disclosed by the invention, third-generation and fourth-generation dendrimer polypropyleneimine (POPAM) are respectively taken as a core, and POPAM is connected with an ion binding site benzo-21-crown ether-7 through a urea bond. Intramolecular hydrogen bond constraint enables GnC7 to present a symmetrical butterfly-shaped topology structure, and the channel has unique motion characteristics, and finally, efficient potassium ion transmembrane transmission with highest potassium-sodium selectivity up to now is realized. The dynamic characteristic is used as the core attribute of GnC7, so that the channel can adjust the potassium ion transmission rate according to the membrane tension change caused by mechanical force. Meanwhile, benzylamine hexafluorophosphate Bh influenced by pH is used as a blocking agent of GnC7 through a host-guest specific compounding effect, and switching of pH-regulated potassium ion transmission can be realized.
Owner:HANGZHOU NORMAL UNIVERSITY

Equipment for improving medicine absorption based on low-frequency resonance

A device for improving medicine absorption based on low-frequency resonance comprises a physical therapy bin, a physical therapy area is arranged in the physical therapy bin, and a far infrared module irradiating a human body and a resonance module composed of a plurality of resonance chips are arranged in the physical therapy area of the physical therapy bin. A plurality of resonance chips of the resonance module are distributed in a cloud gathering manner to form a phase-controlled resonance array, the resonance module further comprises a micro-electric release chip and a processing module, and the micro-electric release module receives an instruction of the processing module to release micro-current according to the distribution of the phase-controlled resonance array. Under the combined action of the far infrared module and the resonance module, a cell sodium and potassium ion channel is regulated and controlled, cell membrane sodium and potassium pump potential change is achieved, cell mitochondrial membrane potential is improved, mitochondria is activated, human cells are more active, the cell metabolism speed is increased, and the drug absorption effect of the cells is enhanced.
Owner:SHIBEIHAO MEDICAL TECHNOLOGY (FOSHAN) CO LTD

Kcr1 mutant suitable for regulating potassium ion homeostasis of plants and application thereof

ActiveCN120329403BPlant peptidesFermentationBiotechnologyPotassium channel
The application discloses a KCR1 mutant suitable for plant potassium ion homeostasis regulation and application thereof, relates to the technical field of bioengineering, and the KCR1 mutant has at least T136A and G140A mutations on the basis of a light-controlled potassium ion channel protein KCR1. The application also discloses a gene encoding the KCR1 mutant. The application also discloses application of the KCR1 mutant or the gene in plant culture, breeding of new plant varieties or preparation of plant culture products. The KCR1 mutant has a blue-shifted excitation spectrum compared with a wild type, and can realize precise regulation of plant potassium ion flow through light regulation, and has great application value in light-controlled plant breeding and research of plant potassium ion channels.
Owner:ZHENGZHOU UNIV

Use and method of osSKOR gene in regulating rice plant height, grain length, grain width and grain weight

PendingCN122326659ABiotechnologyPotassium channel
This invention discloses US The application and methods of genes in regulating rice plant height, grain length, grain width, and grain weight belong to the field of crop genetics and breeding technology. This invention reveals for the first time the potassium ion channel protein gene. US This gene has a pleiotropic function in rice, regulating plant height, grain length, grain width, and grain weight. By silencing or knocking out this gene, rice plant height can be significantly reduced, lodging resistance can be enhanced, and grain length, grain width, and thousand-grain weight can be greatly increased. This overcomes the adverse effect of traditional dwarfing genes often being accompanied by smaller grains, achieving synergistic improvement in dwarfing and grain weight. The discovery of this gene provides a brand-new gene resource and an efficient molecular breeding target for high-yield, high-quality, and lodging-resistant rice breeding, and has important theoretical value and broad application prospects.
Owner:HUNAN AGRI UNIV

Tobacco potassium ion channel NtAKT1 gene and application thereof

The invention belongs to the technical field of genetic engineering, and relates to a gene for regulating and controlling the potassium content of tobacco leaves, in particular to a tobacco potassium ion channel NtAKT1 gene and application thereof. The gene is a potassium ion channel, and the base sequence of the gene is as shown in SEQ ID NO. 1; wherein nucleotides from the 112th site to the 413th site are specific nucleic acid fragments. According to the invention, real-time PCR (polymerase chain reaction) shows that the gene has the highest expression quantity at the root of the tobacco. After a gene transient silencing technology (VIGS) or NtAKT1 gene knockout, the potassium ion content of tobacco leaves is remarkably reduced compared with that of a control group. According to the invention, the transport function of the NtAKT1 gene on the potassium content of the tobacco leaves is defined, a new evidence is provided for analyzing a molecular regulation mechanism of the potassium ion content of the tobacco leaves, a new thought is provided for regulating and cultivating high-potassium-content tobacco leaves through gene expression, and a new gene resource is provided for improving the potassium content of the tobacco leaves through a molecular means.
Owner:ZHENGZHOU TOBACCO RES INST OF CNTC

A compound for preventing and treating pain and its application

ActiveCN114432315BExcellent agonistic activitygood analgesic effectOrganic active ingredientsNervous disorderVisceral painIonic Channels
The present invention discloses an agonist of a TREK-1 potassium ion channel and its application in analgesic therapy. Specifically, the present invention discloses a compound that can activate the TREK-1 potassium ion channel, the compound has a significant analgesic effect, and can be used to prepare a pharmaceutical composition and preparation for preventing and / or treating chronic pain (muscle and soft tissue pain, bone and joint pain, headache, visceral pain, pathological neuralgia), acute pain, and cancer pain.
Owner:EAST CHINA NORMAL UNIV

Living body electric shock current simulation method and device and residual current protection system

PendingCN119047398AConvenient for electric shock protectionAccurately reflect nonlinear characteristicsArrangements responsive to excess currentComputer aided designIonic ChannelsSkin equivalent
The invention discloses a living body electric shock current simulation method and device and a residual current protection system, and the method comprises the steps: respectively connecting a skin equivalent model in series at two ends of an in-vivo equivalent model to construct a living body electric shock model, and connecting a variable resistance branch and a skin equivalent capacitance branch in parallel to form the skin equivalent model, the excitable extracellular fluid path and the in-vivo conductive path are connected in parallel to form an in-vivo equivalent model, the excitable extracellular fluid path comprises a plurality of cell branches, and each cell branch comprises a plurality of sodium and potassium ion channels for equivalent depolarization and repolarization processes; setting model parameters of the living body electric shock model; and starting simulation control when the target organism electric shock model receives the effective stimulation, realizing a polarization state by controlling the on-off of each sodium ion channel and each potassium ion channel, closing all the potassium ion channels after polarization is completed, and counting the current values of the channels to obtain an electric shock current value. According to the invention, the electric shock current can be obtained by accurately simulating the electric shock characteristics of an organism.
Owner:STATE GRID HUNAN ELECTRIC POWER COMPANY LIMITED +2

Polysubstituted aryl derivative as well as preparation method and application thereof

The invention relates to a polysubstituted aryl derivative, a preparation method of the polysubstituted aryl derivative and application of a pharmaceutical composition containing the polysubstituted aryl derivative in medicine. Specifically, the invention relates to a polysubstituted aryl derivative as shown in a general formula (I), a preparation method and a medicinal salt thereof, and application of the polysubstituted aryl derivative as a therapeutic agent, especially as a Kv1.3 potassium channel inhibitor, and definition of each substituent in the general formula (I) is the same as that in the specification.
Owner:ZHEJIANG HISUN PHARMA CO LTD +1

Kv7 potassium ion channel opener as well as preparation method and application thereof

The invention belongs to the technical field of heterocyclic compounds, and particularly relates to a Kv7 potassium ion channel opener as well as a preparation method and application thereof. The method comprises the following steps: adding a compound 1, a compound 2 and triethylamine into ethyl acetate, and carrying out a first reaction to obtain a reaction solution; performing extraction, water washing, drying and vacuum concentration on the reaction liquid, and then adding the reaction liquid into a mixed solution of a sodium hydroxide aqueous solution and isopropanol to perform a second reaction to obtain a compound 3; adding the compound 3, a catalyst and NH4HCO2 into the mixed solvent, and carrying out amination reaction to obtain a compound 4; and adding the compound 4, the compound 5 and triethylamine into ethyl acetate for reaction to obtain the Kv7 potassium ion channel opener. The metabolic stability and the structural rigidity are improved.
Owner:QILU SCHOOL OF MEDICINE

Quinazolines as potassium ion channel inhibitors

PendingUS20250230144A1Organic active ingredientsOrganic chemistryMedicinePotassium channel
A compound of formula Iwherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Owner:BRISTOL MYERS SQUIBB CO

Synergistic composition containing isoxazoline insecticidal and acaricide and application thereof

PendingCN121336822ABiocideAnimal repellantsEnzyme Inhibitor AgentNicotinic Acetylcholine Receptor Agonist
The invention discloses a synergistic composition containing isoxazoline insecticidal and acaricide, which is composed of a compound I and a compound II, the compound I is CCXN-15-005-S (S configuration) or an agrochemically acceptable salt thereof, and the compound II is CCXN-15-005-S (S configuration) or an agrochemically acceptable salt thereof. The compound II is selected from any one of a nicotinic acetylcholine receptor agonist, a chordinal TRPV channel regulator, an acetyl-coenzyme A carboxylase (ACCase) inhibitor, a mitochondrial electron transfer inhibitor, a calcium-activated potassium ion channel regulator and trifluoroethyl thioether (sulfoxide) or an agrochemically acceptable salt thereof. The synergistic composition can be used for preventing and treating pests and harmful mites of thysanoptera, hemiptera and acarus and has a wider agricultural application prospect.
Owner:SHANDONG DEHAO CHEMICAL CO LTD +2

Kit for detecting heart potassium ion channel coding gene idiopathic ventricular fibrillation risk gene SNP (Single Nucleotide Polymorphism) site

The invention relates to a kit for detecting heart potassium ion channel coding gene idiopathic ventricular fibrillation risk gene SNP (Single Nucleotide Polymorphism) loci, which comprises 38 pairs of specific multiplex PCR (Polymerase Chain Reaction) primer pairs with 41 required SNP loci, 41 SNP single-base extension primers, and necessary PCR reaction liquid, SNaPshot reaction liquid, shrimp alkaline phosphatase and exonuclease I. The kit is used for detecting heart potassium ion channel coding gene idiopathic ventricular fibrillation risk gene SNP loci. According to the kit, the multiple PCR technology, the SNaPshot micro-sequencing technology and the capillary electrophoresis technology are combined to screen the risk gene SNP sites related to the idiopathic ventricular fibrillation on the heart potassium ion channel coding genes, the SNP related to the idiopathic ventricular fibrillation on 41 potassium ion channel genes can be detected only through one experiment, a clear conclusion can be obtained, and result interpretation is simple and objective.
Owner:JIAXING UNIV

Method for inhibiting neuronal hyperexcitability via AAV-mediated expression of potassium channel

PCT designated stageWO2026149575A1NucleotidePotassium channel
The present application relates to a method for inhibiting neuronal hyperexcitability via AAV-mediated expression of a potassium channel. The present application relates to a recombinant adeno-associated virus vector (rAAV vector) for inhibiting neuronal hyperexcitability. The rAAV vector comprises a nucleotide sequence encoding a potassium channel. Further, the present application also relates to a virus particle comprising the rAAA vector, a pharmaceutical composition comprising the rAAA vector and / or the virus particle, and a use thereof in the preparation of a drug for treating diseases related to neuronal hyperexcitability.
Owner:GENANS BIOTECHNOLOGY CO LTD

A butterfly-shaped potassium ion channel molecule with dual mechanical and pH regulation, and its preparation method and application

The present invention provides a butterfly-shaped potassium ion channel molecule and its preparation method and application for mechanical and pH dual regulation, belonging to the field of biomimetic material technology. The butterfly-shaped potassium ion channel molecule of the present invention is respectively based on three-generation and four-generation dendrimer polypropylene imine (POPAM), and POPAM and ion binding site benzo-21-crown ether-7 are connected with urea bonds. Intramolecular hydrogen bond constraint causes GnC7 to present a symmetrical "butterfly-shaped" topological structure, and the channel has unique motion characteristics, and ultimately achieves efficient and so far the highest potassium-sodium selectivity across the membrane transport of potassium ions. Dynamic characteristics, as the core attribute of GnC7, enable the channel to regulate potassium ion transmission rate according to the membrane tension changes caused by mechanical force. Meanwhile, benzylamine hexafluorophosphate Bh, which is affected by pH, acts as a blocker of GnC7 through host-guest specific composite action, which can realize the switch for pH regulation potassium ion transmission.
Owner:HANGZHOU NORMAL UNIVERSITY

A traditional Chinese medicine composition for regulating calcium ion homeostasis in the stomach

This invention discloses a traditional Chinese medicine composition for regulating calcium ion homeostasis in the stomach, belonging to the field of traditional Chinese medicine technology. It is made from calcined oyster shell, calcined abalone shell, dried plum, poria cocos, and jujube seed in a specific weight ratio. This invention selects highly efficient calcium sources, calcined oyster shell and calcined abalone shell, in equal proportions, avoiding the deficiency of insufficient calcium content in traditional calcined dragon bone. It targets and supplements local calcium ions in the stomach, enhances the stabilizing effect of calcium ions on potassium ion channels, inhibits abnormal potassium ion leakage, and improves gastrointestinal smooth muscle tone. At the same time, it eliminates unsuitable medicinal materials such as Codonopsis pilosula, Astragalus membranaceus, Eucommia ulmoides, and Lycium barbarum. It uses Prunus mume to inhibit the proliferation of harmful bacteria in the small intestine and reduce fermentation and gas production, Poria cocos to supplement gastrointestinal trace elements, and Ziziphus jujuba var. spinosa to stabilize potassium ion channels, restore the calcium-potassium ion balance in the stomach, improve gastrointestinal motility rhythm, and alleviate problems such as small intestinal bacterial overgrowth, insufficient gastrointestinal motility, and abdominal distension. This composition does not contain sucrose, maltodextrin, chemical additives, or irritating excipients. It is fully decocted and suitable for people with fragile gastrointestinal barriers and immune sensitivity. The raw materials are safe and readily available, the preparation method is simple, and it has broad application prospects in gastrointestinal conditioning.
Owner:杨佳茜

Methods of making and uses of formulations targeting micro ribonucleic acid 145b for antiepileptic uses

The application discloses an antiepileptic preparation preparation method and application of a micro ribonucleic acid 145b targeting agent, and relates to the technical field of biological medicine. The method comprises the following steps: constructing a neuron-specific recombinant adeno-associated virus plasmid vector, wherein the vector comprises a neuron-specific promoter hSyn, a reporter gene, an enhancer, and a functional nucleic acid sequence for targeting and inhibiting micro ribonucleic acid 145b; using an adeno-associated virus packaging system to transfect the vector to a packaging cell for virus packaging; collecting a lysis solution and separating out a recombinant adeno-associated virus particle through a purification process; and resuspending the virus particle to obtain a preparation. The application specifically down-regulates the miR-145b level in hippocampal neurons, releases the inhibition of the Kcnq3 potassium ion channel, further up-regulates the Kcnq3 expression, restores the M current, and reduces the neuron excitability from a molecular mechanism.
Owner:THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY

A compound with endoplasmic reticulum targeting and its application

The present invention discloses a compound with endoplasmic reticulum targeting and its application. The compound has the following chemical formula: #imgabs0# The compound provided by the present invention has good endoplasmic reticulum targeting and the ability to induce the production of type I reactive oxygen species. In addition, the compound can induce time-dependent depletion of endoplasmic reticulum calcium in cancer cells under light conditions. More importantly, the existing anti-diabetic drug glibenclamide closes the ATP-dependent potassium ion channel (K) on the endoplasmic reticulum membrane. + ATP ), the compound-induced loss of endoplasmic reticulum calcium into the cytoplasm will lead to severe depolarization of the endoplasmic reticulum membrane potential, and ultimately activate the downstream endoplasmic reticulum and mitochondria-dependent apoptosis pathways, leading to cancer cell death, while also embodying the new use of glibenclamide.
Owner:GUANGZHOU MEDICAL UNIV

6,7-dihydro-5h-pyrrolo[1,2-a]imidazole derivative, preparation method therefor, and use thereof

PCT designated stageWO2026025999A1Organic active ingredientsOrganic chemistryPotassium channelIonic Channels
The present invention relates to a 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole derivative, a preparation method therefor, and a medical use of a pharmaceutical composition containing the derivative. Specifically, the present invention relates to a 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole derivative as shown in general formula (I), a preparation method therefor, and a pharmaceutically acceptable salt thereof, as well as a use thereof as a therapeutic agent, particularly as a Kv1.3 potassium channel inhibitor. The definitions of the substituents in general formula (I) are the same as those defined in the description.
Owner:ZHEJIANG HISUN PHARMA CO LTD +1

ATP-sensitive potassium channel inhibitor and pharmaceutical composition containing same

The present invention addresses the problem of providing a new ischemic disease treatment strategy targeting pericytes. As a solution, the present invention provides an inflammation suppressant or a tissue protective agent for ischemic injury, each including an inhibitor which blocks ATP-sensitive potassium (KATP) channels present in a pericyte. In particular, the KATP channel is composed of pore-forming KIR6.1 and regulatory SUR2 subunits, and it is preferable for the inhibitor to act on the KIR6.1. The inflammation suppressant or the tissue protective agent for ischemic injury is preferably used in the treatment of ischemic diseases such as cerebral infarction or ischemic cardiac disease.
Owner:NAT CEREBRAL & CARDIOVASCULAR CENT

Kv7 Potassium Ion Channel Openers and Their Preparation Methods and Applications

The present invention belongs to the technical field of heterocyclic compounds, and particularly relates to a Kv7 potassium ion channel opener, a preparation method thereof and an application thereof. Compound 1, compound 2 and triethylamine are added to ethyl acetate for a first reaction to obtain a reaction solution; the reaction solution is subjected to extraction, washing with water, drying, and concentration under reduced pressure, and then added to a mixed solution of an aqueous sodium hydroxide solution and isopropanol for a second reaction to obtain compound 3; compound 3, a catalyst and NH4HCO2 are added to a mixed solvent for an amination reaction to obtain compound 4; compound 4, compound 5 and triethylamine are added to ethyl acetate for a reaction to obtain a Kv7 potassium ion channel opener. The present invention improves the metabolic stability and the rigidity of the structure.
Owner:QILU SCHOOL OF MEDICINE